Safe, controlled, and high performing

SUKANO® Antiviral Masterbatches
protect surfaces from acting as a transmitter.

Find out more

Advantages 

of the MB solutionSUKANO 

SUKANO® Antimicrobial/Antiviral Masterbatches for medical applications provide an additional robust and scientifically proven safety layer that helps prevent viral and bacterial transmission on product surfaces. Reducing waste and energy in manufacturing and processing of devices, saving natural resources. The benefit and protection demonstrated extends beyond medical devices, to other surfaces in the medical environment such as furniture, door handles, light switches, PPE , textiles and more.

Reduce/eliminate coating and associated risks of microbiological or cross contamination

Allows secondary processing steps, e.g.printing and labelling

Little to no side effects of masterbatch formula with other additives e.g.UVs, colors, etc.

Reduced costs due no cleaning requirements residues on machinery and no additional processing steps as associated to coatings

Immediate activity after production

Antiviral Masterbatches also available in biobased material

Find out

more

A global network of experts

Our global network of experts allows us to be the partner of choice for masterbatches and compounds

Go to article: Home | Once more unto the (data) breachGo to article: In this issueGo to article: ContentsGo to article: SHL MedicalGo to article: SHL Medical Company Insight Go to article: Datwyler Company InsightGo to article: DatwylerGo to article: LabcorpGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: BaxterGo to article: Sukano Company InsightGo to article: SukanoGo to article: CommentGo to article: Use of off-label therapies increases the need for reliable clinical trial dataGo to article: Unmet needs remain in the neuroendocrine tumour treatment paradigmGo to article: Drinking alcohol raises risk of oesophageal and other cancersGo to article: Verder Company InsightGo to article: VerderGo to article: RegPakGo to article: Avery DennisonGo to article: In DepthGo to article: Pharma cybersecurity breaches to know and learn fromGo to article: The drugs treating alcoholism Go to article: In with the old: how an established vaccine is fuelling Covid-19 treatmentGo to article: How are hospitals tackling pharmaceutical pollution?Go to article: After Covid-19, mRNA technology aims to revolutionise the flu shotGo to article: Pushing for a UK genomics revolutionGo to article: MicronovaGo to article: Pfeiffer VacuumGo to article: HOF SonderanlagenbauGo to article: In DataGo to article: Data: pharma subsidiaries Go to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue